Stocktoria
PERRIGO Co plc PRGO
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1991-12-17
PERRIGO Co plc financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.3B | $4.4B | $4.7B | $4.5B | $4.1B |
| Gross profit | $1.5B | $1.5B | $1.7B | $1.5B | $1.4B |
| R&D expense | $95.4M | $112.2M | $122.5M | $123.1M | $122.0M |
| Operating income | -$1.1B | $112.9M | $151.9M | $78.9M | $410.4M |
| Income tax | $104.4M | $80.0M | -$3.9M | -$8.2M | $389.6M |
| Net income | -$1.4B | -$171.8M | -$12.7M | -$140.6M | -$68.9M |
| EPS (diluted) | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 |
| Operating cash flow | $238.5M | $362.9M | $405.5M | $307.3M | $156.3M |
| Free cash flow | $145.1M | $244.6M | $303.8M | $210.9M | $4.2M |
| Cash & equivalents | — | $558.8M | $751.3M | $600.7M | $1.9B |
| Inventory | $1.1B | $1.1B | $1.1B | $1.2B | $1.0B |
| Total assets | $8.5B | $9.6B | $10.8B | $11.0B | $10.4B |
| Total liabilities | $5.6B | $5.3B | $6.0B | $6.2B | $5.3B |
| Shareholders' equity | $2.9B | $4.3B | $4.8B | $4.8B | $5.2B |
Source: SEC EDGAR filings · CIK 0001585364 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.